Primary Site >> Pancreatic Cancer
Gene >> CHGA
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Plasma chromogranin A in patients with multiple endocrine neoplasia type 1. PMID: 10443665 Ref: [A clinicopathological study of pancreatoblastoma]. PMID: 11869544 |
Ref: Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. PMID: 10697270 Ref: Neuroendocrine differentiation in ovarian mucinous tumors. PMID: 11775215 |
Ref: Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas. PMID: 11579680 |
Ref: [Diagnostic and therapeutic difficulties in MEN 1 syndrome]. PMID: 16350723 |
Ref: Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer. PMID: 18329114 Ref: [Clinical pathological analysis in 14 cases of pancreatic solid-pseudopapillary tumors]. PMID: 20019775 |
Ref: Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. PMID: 19933912 Ref: Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia. PMID: 20938461 |
Ref: Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumors. PMID: 20623205 Ref: [The diagnostic value of plasma chromogranin A in neuroendocrine tumors]. PMID: 21418832 Ref: Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors. PMID: 21606156 Ref: Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors. PMID: 22009449 Ref: Usefulness of chromogranin A, neuron-specific enolase and 5-hydroxyindolacetic acid measurements in patients with malignant carcinoids. PMID: 22021701 |
Ref: [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases]. PMID: 24989916 |
Ref: A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases. PMID: 27000717 Ref: Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes. PMID: 27757796 |
Ref: Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors PMID: 28501118 |
Ref: Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology. PMID: 29472376 Ref: Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. PMID: 30366884 |